Medicine
fromFuturism
6 days agoCrypto Company Creates Bizarre Drug
AI-assisted FDA review enabled a crypto-linked company to advance Nalmefene (TH104), a longer-lasting opioid antagonist marketed for first responders, raising safety and credibility concerns.